Updates from Industry and New Technology Symposia, Friday 9th September, 2022 in Nice, France: 14th Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT)
Article Information
Volume 8 Issue 2 December 2022, pages 28-33
Received; 24th November 2022; Accepted: 30th November 2022
URS FISCHER – Department of Neurology, University of Basel, Switzerland
MARIOS-NIKOS PSYCHOGIOS – Department of Neuroradiology, University Hospital Basel, Switzerland
LUIS MORALES CARDONA – Vice-President of Research, Development and Technology, Medtronic Neurovascular and CSF, Irvine, California, USA
Abstract:
These presentations were sponsored by Medtronic as part of the 14th Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT), in Nice, France. At the Industry Symposium on Friday 09 September 2022, Professor Urs Fisher presented the background to the evidence leading to the results of the SWIFT DIRECT trial and Professor Marios-Nikos Psychogios gave an account of his experience using the 3 mm SolitaireTM X device. At the New Technology Symposium, also held on Friday 09 September 2022, Luis Morales Cardona of Medtronic presented a product overview of the RistTM Radial Access System
Keywords:
ENDOVASCULAR THERAPY, INTRAVENOUS, REPERFUSION, RISTTM, SOLITAIRETM X, SWIFT DIRECT, THROMBECTOMY, THROMBOLYSIS.Follow Us
Newsletter
Keep up to date with our latest
articles and journals
0 Comments